Published March 17, 2021, 6:17 PM
Over 1,300 coronavirus disease (COVID-19) patients have participated in the Solidarity Treatment Trial of the World Health Organization (WHO), the Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) said Wednesday, March 17.
DOST-PCHRD Executive Director Dr. Jaime C. Montoya cited the Philippines’ active participation in ongoing global efforts to halt the pandemic, such as the World Health Organization’s Solidarity Trials for COVID-19 treatments.
“As of January 31, 2021, a total of 1,315 subjects have joined the megatrial in the Philippines, with 730 patients enrolled in public hospitals and 585 in private hospitals,” he said in his welcome remarks during the Council’s 39th founding anniversary celebration
(FACEBOOK/MANILA BULLETIN)
Despite the risks, DOST still continued its mission to harness science, technology, and innovation (STI) to provide various interventions and deliver services that will promote inclusive socio-growth and development to the country.
DOST even helped placed the country to a much higher spot in the Global Innovation Index (GII) from its former rank of 100th six years ago.
In terms of Research and Development (R&D), many of DOST’s programs still pushed on, even with the COVID-19 pandemic. However, when it comes to comparing expenditures with its Asian neighbors, the Philippines was at the bottom of the list, according to its top official.
Don t use trumpets, whistles to welcome 2021, DOH warns public inquirer.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.net Daily Mail and Mail on Sunday newspapers.